The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it hasn’t been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms associated with this condition, for example dov rand sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men’s heart health was carefully monitored.
Research has shown that testosterone deficiency is associated with a number of critical health problems including metabolic syndrome, obesity, diabetes, and bone fractures Guys who meet medical criteria for treatment should receive therapy. Actually, your testosterone levels have probably been slowly falling for quite some time, a downfall that usually begins around age 30.
And many women have a knee jerk suspicion that any hormone treatment can increase their risk of breast cancer. Nevertheless, clinical studies demonstrate that testosterone not only doesn’t increase a woman’s risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably stay the status quo for a little while, given the prohibitive cost of conducting the long term safety studies needed to acquire fuller FDA approval.